Literature DB >> 10493623

Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma.

C E Cox1, S S Bass, D Boulware, N K Ku, C Berman, D S Reintgen.   

Abstract

BACKGROUND: Recent advances in technology and the subsequent development of minimally invasive surgical techniques have heralded a new era in the surgical treatment of breast cancer. The dilemma of how to train surgeons in new technologies requires teaching, certification, and outcomes reporting in a non-threatening and non-economically damaging manner. This study examines 700 cases of lymphatic mapping and sentinel lymph node (SLN) biopsy for breast cancer and documents surgeon-specific and institution-specific learning curves.
METHODS: Seven hundred cases of lymphatic mapping and SLN biopsy were examined. All procedures were performed using a combination of vital blue dye and radiolabeled sulfur colloid. Learning curves were generated for each surgeon as a plot of failure rate versus number of cases.
RESULTS: Examination of the learning curves in this study demonstrates similar characteristics. Following a high initial failure rate, there is a rapid decrease after the first twenty cases. The learning curve, representing the mean of the five surgeons' experience, indicates that 23 cases and 53 cases are required to achieve success rates of 90% and 95%, respectively.
CONCLUSIONS: The initial reports regarding lymphatic mapping combined with this experience of 700 cases confirm the presence of a significant learning curve. Although this procedure may have an inherent failure rate, it is important to identify those factors that are under the control of the surgeon and, therefore, subject to improvement. We believe that these data provide surgeons performing lymphatic mapping and SLN biopsy with a new paradigm for assessing their skill and adequacy of training.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493623     DOI: 10.1007/s10434-999-0553-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  Lymphatic mapping and sentinel lymph node biopsy for breast cancer patients.

Authors:  Lisa A Newman
Journal:  J Oncol Pract       Date:  2005-11       Impact factor: 3.840

2.  Breast Cancer OncoGuia.

Authors:  Paula Manchon; Josep M Borràs; Tàrsila Ferro; Josep Alfons Espinàs
Journal:  Clin Transl Oncol       Date:  2010-02       Impact factor: 3.405

3.  Ex vivo sentinel node mapping in carcinoma of the colon and rectum.

Authors:  J H Wong; S Steineman; C Calderia; J Bowles; T Namiki
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

4.  Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.

Authors:  Katherine E Posther; Linda M McCall; Peter W Blumencranz; William E Burak; Peter D Beitsch; Nora M Hansen; Monica Morrow; Lee G Wilke; James E Herndon; Kelly K Hunt; Armando E Giuliano
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

5.  Practice patterns in breast cancer surgery: Canadian perspective.

Authors:  Geoffrey A Porter; Heather McMulkin-Tait
Journal:  World J Surg       Date:  2003-11-26       Impact factor: 3.352

Review 6.  Clinical aspects of sentinel node biopsy.

Authors:  H S Cody
Journal:  Breast Cancer Res       Date:  2001-01-23       Impact factor: 6.466

7.  Sentinel node biopsy for breast cancer: is it already a standard of care? A survey of current practice in an Italian region.

Authors:  Giorgio Zavagno; Gian Luca De Salvo; Dario Casara; Paola Del Bianco; Domenico Rubello; Fabrizio Meggiolaro; Carlo Riccardo Rossi; Mariaelena Pierobon; Mario Lise
Journal:  BMC Cancer       Date:  2004-01-22       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.